EA202092395A1 - AXL KINASE INHIBITORS AND THEIR APPLICATION - Google Patents

AXL KINASE INHIBITORS AND THEIR APPLICATION

Info

Publication number
EA202092395A1
EA202092395A1 EA202092395A EA202092395A EA202092395A1 EA 202092395 A1 EA202092395 A1 EA 202092395A1 EA 202092395 A EA202092395 A EA 202092395A EA 202092395 A EA202092395 A EA 202092395A EA 202092395 A1 EA202092395 A1 EA 202092395A1
Authority
EA
Eurasian Patent Office
Prior art keywords
application
kinase inhibitors
axl kinase
tartrates
solid tumors
Prior art date
Application number
EA202092395A
Other languages
Russian (ru)
Inventor
Адам СИДДИКВИ-ДЖАИН
Стивен Л. Уорнер
Пол Флинн
Дэвид Дж. Беарсс
Джейсон Марк Фоулкс
Нозоми Томимацу
Кен Фудзимура
Хироки Умехара
Акихито Нонояма
Акихито Кигутия
Original Assignee
Сумитомо Даиниппон Фарма Онколоджи, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сумитомо Даиниппон Фарма Онколоджи, Инк. filed Critical Сумитомо Даиниппон Фарма Онколоджи, Инк.
Priority claimed from PCT/US2019/026094 external-priority patent/WO2019195753A1/en
Publication of EA202092395A1 publication Critical patent/EA202092395A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Тартраты соединения структуры (I)их кристаллические формы и их терапевтическое применение для лечения солидных опухолей (например, распространенных солидных опухолей) или гемопоэтического рака. В настоящем изобретении также представлены способы синтеза тартратов и их кристаллических форм.The tartrates of the compound of structure (I) their crystalline forms and their therapeutic use for the treatment of solid tumors (eg, advanced solid tumors) or hematopoietic cancer. The present invention also provides methods for the synthesis of tartrates and their crystalline forms.

EA202092395A 2019-03-04 2019-04-05 AXL KINASE INHIBITORS AND THEIR APPLICATION EA202092395A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962813705P 2019-03-04 2019-03-04
PCT/US2019/026094 WO2019195753A1 (en) 2018-04-05 2019-04-05 Axl kinase inhibitors and use of the same

Publications (1)

Publication Number Publication Date
EA202092395A1 true EA202092395A1 (en) 2021-03-11

Family

ID=75262250

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202092395A EA202092395A1 (en) 2019-03-04 2019-04-05 AXL KINASE INHIBITORS AND THEIR APPLICATION

Country Status (1)

Country Link
EA (1) EA202092395A1 (en)

Similar Documents

Publication Publication Date Title
CR20200518A (en) Pyridazinones as parp7 inhibitors
BR112019024525A2 (en) compound, pharmaceutically acceptable salt and pharmaceutical formulation of c12c kras inhibitors
PH12020551853A1 (en) Axl kinase inhibitors and use of the same
PH12018502102A1 (en) Pyrrolotriazine compounds as tam inhibitors
ECSP22011692A (en) IMIDAZOLIL PYRIMIDINILAMINE COMPOUNDS AS CDK2 INHIBITORS
PH12020551717A1 (en) Dual atm and dna-pk inhibitors for use in anti-tumor therapy
EA201990187A1 (en) PYRIMIDINE ANTIPROLIFERATION AGENTS
EA202090497A1 (en) COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF HEMATOLOGICAL DISORDERS
EA201891229A1 (en) EIF4A-INHIBITING COMPOUNDS AND RELATED METHODS
PH12018500587A1 (en) Pyrazolopyrimidine derivatives as btk inhibitors for the treatment of cancer
MX2020014245A (en) Inhibitors of cyclin-dependent kinases.
EA201892229A1 (en) SUBSTITUTED AMINOPURIN COMPOUNDS CONTAINING THEIR COMPOSITIONS AND TREATMENT METHODS WITH THEIR APPLICATION
EA201790492A1 (en) CONNECTIONS THAT INHIBIT McL-1 PROTEIN
EA201991884A2 (en) G12C KRAS INHIBITORS
EA201592199A1 (en) BIPYRAZOL DERIVATIVES AS JAK INHIBITORS
EA201790779A1 (en) SUBSTITUTED AMINOPURIN COMPOUNDS, THEIR COMPOSITIONS AND METHODS OF TREATMENT USING SUCH CONNECTIONS
EA202193015A1 (en) CDK INHIBITORS
EA201991700A1 (en) SELECTIVE INHIBITORS JAK1
EA201991894A1 (en) PIPERIDINE-SUBSTITUTED Mnk INHIBITORS AND RELATED WAYS
MX2020010942A (en) Dual atm and dna-pk inhibitors for use in anti-tumor therapy.
MX2023004802A (en) Heterocyclic spiro compounds and methods of use.
EA201100126A1 (en) NAFTHYRIDINOES AS PROTEINKINAZ INHIBITORS
MX2018008507A (en) Inhibiting ataxia telangiectasia and rad3-related protein (atr).
EA202092395A1 (en) AXL KINASE INHIBITORS AND THEIR APPLICATION
EA201792676A1 (en) JAK1 INHIBITORS